Youre already counseling about weight
Many diabetes treatments also impact weight loss and obesity medication such as GLP-1 agonists, combined with healthy lifestyle interventions, can positively impact morbidities associated with diabetes and obesity.1 Patients with Type 2 diabetes have diminished responses of incretin hormones compared to healthy individuals
This one strategy, acknowledged by many experienced researchers and clinicians, prevents a huge amount of unnecessary suffering and premature discontinuation
Pennsylvania projects it will spend $1.3 billion on GLP-1 drugs this year
Neuroprotective mechanisms of glucagon-like Peptide-1-based therapies in ischemic stroke: an update based on preclinical research
hrs.2025.107770 Chen SD, Chuang YC, Lin TK, Yang JL (2023) Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases